{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:42Z","timestamp":1787798682127,"version":"build-2784847793"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The diagnosis of transthyretin amyloidosis (ATTR) significantly impacts the management and prognosis of patients initially presenting with heart failure (HF). Despite recent advancements in treatment, prognosticating ATTR remains challenging. In this study, we aim to assess echocardiographic parameters associated with mid-term prognosis in patients with wild-type ATTR using a biomarker staging system as a reference point.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We studied 182 consecutive patients with wild-type ATTR (91% male and median age 82 years) who were referred to our centre between 2016 and 2022. Using N-terminal pro-B-type natriuretic peptide and estimated glomerular filtration rate cut-offs, we classified patients into the following three stages: Stage I (101 patients, 55.5%), Stage II (53 patients, 29.0%), and Stage III disease (28 patients, 15.5%). We then compared traditional echocardiographic indices and markers of subclinical ventricular dysfunction [left ventricular (LV) global longitudinal strain, right ventricular (RV) free wall strain, and left atrial (LA) strain] among groups. Over a fixed follow-up period of 18 months, which included treatment with tafamidis 61\u2005mg daily, 48 patients (26.4%) experienced the composite outcome of death or HF hospitalization. When compared with Stage I ATTR, the hazard ratio (HR) for death or hospitalization was 1.55 [95% confidence interval (CI) 0.62\u20133.86] for Stage II ATTR and 4.53 (95% CI 1.66\u201312.4, P = 0.0116) for Stage III ATTR. Among echocardiographic parameters, reduced RV free wall strrain (FWS) was independently associated with all-cause mortality or HF hospitalization after adjustment for the staging system (HR 2.03, 95% CI 1.07\u20133.85, P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>RV FWS should be routinely assessed for all patients with ATTR. It is an independent predictor of poor prognosis and provides additional value beyond biomarker staging systems.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeae242","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T14:00:47Z","timestamp":1726668047000},"page":"239-248","source":"Crossref","is-referenced-by-count":11,"title":["Right ventricular free wall strain predicts transthyretin amyloidosis prognosis as well as biomarker-based staging systems"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-0983","authenticated-orcid":false,"given":"Sabina","family":"Istratoaie","sequence":"first","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]},{"name":"Department of Pharmacology, Toxicology, and Clinical Pharmacology, Iuliu Ha\u0163ieganu University of Medicine and Pharmacy , Cluj-Napoca ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7074-4839","authenticated-orcid":false,"given":"Corentin","family":"Bourg","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6868-7377","authenticated-orcid":false,"given":"K Charlotte","family":"Lee","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0542-0335","authenticated-orcid":false,"given":"Benjamin","family":"Marut","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Antonelli","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"L\u2019official","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-6134","authenticated-orcid":false,"given":"Adrien Al","family":"Wazzan","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2677-3389","authenticated-orcid":false,"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[{"name":"CHU Rennes, Inserm, LTSI\u2014UMR 1099, University of Rennes , 2 Rue Henri le Guilloux, Rennes F-35000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"2025013023574639600_jeae242-B1","doi-asserted-by":"crossref","first-page":"111753","DOI":"10.1016\/j.ejmech.2019.111753","article-title":"Molecular and clinical insights into protein misfolding and associated amyloidosis","volume":"184","author":"Pande","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2025013023574639600_jeae242-B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B3","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025013023574639600_jeae242-B4","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"2025013023574639600_jeae242-B5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2025013023574639600_jeae242-B6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025013023574639600_jeae242-B7","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"2025013023574639600_jeae242-B8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2025013023574639600_jeae242-B9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","article-title":"A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work","volume":"33","author":"Russell","year":"2012","journal-title":"Eur Heart J"},{"key":"2025013023574639600_jeae242-B12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","article-title":"Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"19","author":"Badano","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ehf2.14189","article-title":"Isolated functional tricuspid regurgitation: how to define patients at risk for event?","volume":"10","author":"L\u2019Official","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2025013023574639600_jeae242-B14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","volume":"2","author":"Cheng","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2025013023574639600_jeae242-B15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic utility of echocardiographic atrial and ventricular strain imaging in patients with cardiac amyloidosis","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.01.361","article-title":"Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis","volume":"103","author":"Austin","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025013023574639600_jeae242-B17","doi-asserted-by":"crossref","first-page":"e006588","DOI":"10.1161\/CIRCIMAGING.117.006588","article-title":"Independent prognostic value of stroke volume index in patients with immunoglobulin light chain amyloidosis","volume":"11","author":"Milani","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2025013023574639600_jeae242-B20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ehjci\/jead318","article-title":"Evolution and prognostic value of left ventricular deformation and myocardial work parameters in transthyretin amyloid cardiomyopathy","volume":"25","author":"Antonelli","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCIMAGING.108.813071","article-title":"Left atrial function in diastolic heart failure","volume":"2","author":"Kurt","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ehjci\/jeac057","article-title":"Multi- chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025013023574639600_jeae242-B24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaccao.2020.10.010","article-title":"Left atrial mechanics associates with paroxysmal atrial fibrillation in light-chain amyloidosis following stem cell transplantation","volume":"2","author":"Lohrmann","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2025013023574639600_jeae242-B25","doi-asserted-by":"crossref","first-page":"e001808","DOI":"10.1136\/openhrt-2021-001808","article-title":"Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis","volume":"9","author":"Slivnick","year":"2022","journal-title":"Open Heart"},{"key":"2025013023574639600_jeae242-B26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13506129.2018.1493989","article-title":"Right ventricular involvement in transthyretin amyloidosis","volume":"25","author":"Arvidsson","year":"2018","journal-title":"Amyloid"},{"key":"2025013023574639600_jeae242-B27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjcard.2021.12.055","article-title":"Prognostic implications of right ventricular free wall strain in recipients of cardiac resynchronization therapy","volume":"171","author":"Stassen","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025013023574639600_jeae242-B28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cjca.2020.01.020","article-title":"Determinants and prognostic significance of serial right heart function changes in patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"2025013023574639600_jeae242-B29","doi-asserted-by":"crossref","first-page":"oead048","DOI":"10.1093\/ehjopen\/oead048","article-title":"Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis","volume":"3","author":"Usuku","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2025013023574639600_jeae242-B30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2022.02.048","article-title":"Prognostic implications of right ventricular systolic dysfunction in cardiac amyloidosis","volume":"173","author":"Tjahjadi","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025013023574639600_jeae242-B31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ehjci\/jead145","article-title":"Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis","volume":"24","author":"Tomasoni","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeae242\/59644294\/jeae242.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/2\/239\/59644294\/jeae242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/2\/239\/59644294\/jeae242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:58:00Z","timestamp":1738281480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/26\/2\/239\/7760098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2025,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeae242","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,9,18]]}}}